Arterys Receives First FDA Clearance for Broad Oncology Imaging Suite with Deep Learning

SAN FRANCISCO -- Arterys Inc., the leader in intelligent, cloud-based medical imaging software solutions, today announced its fifth 510(k) clearance from the U.S. Food and Drug Administration (FDA). The clearance is for the Arterys Oncology AI suite, and is a milestone indicative of the company's momentum in applying AI to advance medical imaging accuracy and consistency

Parth Desai